BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23666729)

  • 1. Feature selection and machine learning with mass spectrometry data.
    Datta S
    Methods Mol Biol; 2013; 1007():237-62. PubMed ID: 23666729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feature selection and machine learning with mass spectrometry data.
    Datta S; Pihur V
    Methods Mol Biol; 2010; 593():205-29. PubMed ID: 19957152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feature selection and nearest centroid classification for protein mass spectrometry.
    Levner I
    BMC Bioinformatics; 2005 Mar; 6():68. PubMed ID: 15788095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
    Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiƶ J
    J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guilt-by-association feature selection: identifying biomarkers from proteomic profiles.
    Shin H; Sheu B; Joseph M; Markey MK
    J Biomed Inform; 2008 Feb; 41(1):124-36. PubMed ID: 17544868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI TOF-MS) and ProteinChip technology in proteomics research.
    Seibert V; Wiesner A; Buschmann T; Meuer J
    Pathol Res Pract; 2004; 200(2):83-94. PubMed ID: 15237917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.
    Yasui Y; Pepe M; Thompson ML; Adam BL; Wright GL; Qu Y; Potter JD; Winget M; Thornquist M; Feng Z
    Biostatistics; 2003 Jul; 4(3):449-63. PubMed ID: 12925511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
    Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning methods for predictive proteomics.
    Barla A; Jurman G; Riccadonna S; Merler S; Chierici M; Furlanello C
    Brief Bioinform; 2008 Mar; 9(2):119-28. PubMed ID: 18310105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An extended Markov blanket approach to proteomic biomarker detection from high-resolution mass spectrometry data.
    Oh JH; Gurnani P; Schorge J; Rosenblatt KP; Gao JX
    IEEE Trans Inf Technol Biomed; 2009 Mar; 13(2):195-206. PubMed ID: 19126475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis.
    Novikova SI; He F; Cutrufello NJ; Lidow MS
    Neurobiol Dis; 2006 Jul; 23(1):61-76. PubMed ID: 16549361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid identification of protein biomarkers of Escherichia coli O157:H7 by matrix-assisted laser desorption ionization-time-of-flight-time-of-flight mass spectrometry and top-down proteomics.
    Fagerquist CK; Garbus BR; Miller WG; Williams KE; Yee E; Bates AH; Boyle S; Harden LA; Cooley MB; Mandrell RE
    Anal Chem; 2010 Apr; 82(7):2717-25. PubMed ID: 20232878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices.
    Poon TC
    Expert Rev Proteomics; 2007 Feb; 4(1):51-65. PubMed ID: 17288515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global and targeted quantitative proteomics for biomarker discovery.
    Veenstra TD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Lucid Proteomics System for top-down biomarker research.
    Jourdain S; Bulman A; Dalmasso E
    Arch Physiol Biochem; 2010; 116(4-5):158-62. PubMed ID: 20507259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving feature detection and analysis of surface-enhanced laser desorption/ionization-time of flight mass spectra.
    Carlson SM; Najmi A; Whitin JC; Cohen HJ
    Proteomics; 2005 Jul; 5(11):2778-88. PubMed ID: 15986333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finding diagnostic biomarkers in proteomic spectra.
    Pratapa PN; Patz EF; Hartemink AJ
    Pac Symp Biocomput; 2006; ():279-90. PubMed ID: 17094246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform.
    Oh JH; Pan S; Zhang J; Gao J
    Rapid Commun Mass Spectrom; 2010 Feb; 24(4):403-8. PubMed ID: 20069694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker Signature Discovery from Mass Spectrometry Data.
    Kong A; Gupta C; Ferrari M; Agostini M; Bedin C; Bouamrani A; Tasciotti E; Azencott R
    IEEE/ACM Trans Comput Biol Bioinform; 2014; 11(4):766-72. PubMed ID: 26356346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.